Parkinson´s disease (PD) is a progressive, chronic, and debilitating neurodegenerative disease for which there is no cure and no diagnostic test available. About 10 million people live with PD worldwide (1.2 million in Europe), an...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
eADAM
Ultra small electrochemical aptasensors for specific dopamin...
200K€
Cerrado
SUPD
Sizing Up PD Cavity enhanced Characterisation of Single Bio...
290K€
Cerrado
PID2021-128469OB-I00
DIAGNOSTICO Y EVALUACION DE LA ENFERMEDAD DE PARKINSON USAND...
208K€
Cerrado
FJC2021-046498-I
Neurolinguistic markers for the detection of people with Alz...
65K€
Cerrado
DPI2017-83405-R
BIOMARCADORES PARA EL DIAGNOSTICO Y LA EVALUACION DE LA ENFE...
185K€
Cerrado
FLUBIODEM
Fluid Biomarkers for Neurodegenerative Dementias
2M€
Cerrado
Información proyecto UNMASK
Duración del proyecto: 20 meses
Fecha Inicio: 2024-04-03
Fecha Fin: 2025-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Parkinson´s disease (PD) is a progressive, chronic, and debilitating neurodegenerative disease for which there is no cure and no diagnostic test available. About 10 million people live with PD worldwide (1.2 million in Europe), and this number is expected to double by 2030 due to the aging population. PD has a high social and economic burden, and there is the need to improve PD timely detection and diagnosis, especially in young people.
UNMASK aims to validate the technological and business feasibility of the olfaction-inspired technology developed in the ERC Starting Grant SCENT by establishing the proof-of-concept for the non-invasive and fast PD diagnostics. To accomplish this, we will approach the project from both Technical and Business perspectives, with a perfect synergy between the research and business teams, and a close contact with clinical collaborators and stakeholders.